We Help Companies Find New Sales Opportunities
Lab21 is to acquire Myconostica, the Manchester-based developer of molecular diagnostic products, from Amphion Innovations.
Lab21 has acquired Selah Technologies, the US nanotechnology company, for undisclosed terms.
Lab21 has acquired the business and assets of Delphic Diagnostics, the laboratory services firm with sites in Liverpool and Kent, out of administration for undisclosed terms.
Lab21 has acquired Plasmatec Laboratory Products, the Dorset-based diagnostic tests manufacturer, from Axis-Shield for undisclosed terms.
Lab21 has acquired Biotec Laboratories, the Ipswich-based clinical diagnostics firm, for undisclosed terms.